ONL THERAPEUTICS INC has a total of 16 patent applications. Its first patent ever was published in 2016. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and basic materials chemistry are AKRON BIOTECHNOLOGY LLC, AMP THERAPEUTICS GMBH & CO KG and SARAMANE PTY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | EAPO (Eurasian Patent Organization) | 1 | |
#9 | Hong Kong | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Basic materials chemistry | |
#4 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Preservation of human bodies | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Bridges Alexander J | 12 |
#2 | Sylvain Ethan | 11 |
#3 | Besirli Cagri G | 11 |
#4 | Freshley John K | 11 |
#5 | Smith Francis X | 11 |
#6 | Johnson Linda L | 11 |
#7 | Hunke William A | 11 |
#8 | Zacks David N | 11 |
#9 | Gregory-Ksander Meredith | 3 |
#10 | Freshley John | 3 |
Publication | Filing date | Title |
---|---|---|
EP3768301A1 | Compositions and methods of fas inhibition | |
US2019201500A1 | Compositions and methods of fas inhibition | |
US2018291062A1 | Peptide compositions and methods of use |